Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

95.41EUR
15 Aug 2014
Price Change (% chg)

€-2.28 (-2.33%)
Prev Close
€97.69
Open
€97.78
Day's High
€98.45
Day's Low
€95.03
Volume
2,510,992
Avg. Vol
2,229,862
52-wk High
€121.10
52-wk Low
€91.31

BAYGn.DE

Chart for BAYGn.DE

About

Bayer AG is a German holding company active in the field of health care, nutrition and high-tech materials. It has three subgroups: HealthCare, involved in the research, development and production of health products for people and animals, CropScience, engaged in the crop protection and non-agricultural pest control, and... (more)

Overall

Beta: 0.90
Market Cap (Mil.): €99,523.17
Shares Outstanding (Mil.): 826.95
Dividend: 2.10
Yield (%): 1.74

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 27.21 37.69 38.55
EPS (TTM): 4.42 -- --
ROI: 8.83 17.92 17.25
ROE: 18.18 18.73 18.17
Search Stocks

Bayer resumes efforts to sell diabetes device unit: sources

FRANKFURT - German drugmaker Bayer AG is considering a fresh attempt to sell its diabetes device business as it sharpens its focus on margin-rich healthcare sectors, two people familiar with the matter told Reuters on Tuesday.

25 Nov 2014

UPDATE 1-Bayer resumes efforts to sell diabetes device unit - sources

* Could attract PVEs like Cinven, EQT, Triton - Bloomberg

25 Nov 2014

Bayer explores possible sale of diabetes device unit: Bloomberg

- Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

24 Nov 2014

Bayer explores possible sale of diabetes device unit -Bloomberg

Nov 24 - Germany-based drugmaker Bayer AG is considering the sale of its diabetes device business, Bloomberg reported, citing sources.

24 Nov 2014

Bayer's Eylea gets approval in Japan for DME

FRANKFURT, Nov 18 - Bayer's Eylea treatment has been approved in Japan for the treatment of diabetes-related visual impairment (DME), Germany's largest drugmaker said on Tuesday.

18 Nov 2014

German manufacturing sector rebounds in Oct after Sept dip: PMI

BERLIN, Nov 3 - German factory activity rebounded in October after shrinking slightly in September for the first time in over a year, although there are signs of weak domestic demand in Europe's largest economy, a survey showed on Monday.

03 Nov 2014

BRIEF-Bayer completes acquisition of Dihon Pharmaceutical in China

* Says completes acquisition of Dihon Pharmaceutical Group co., ltd. in China Further company coverage:

03 Nov 2014

Bayer says animal health unit large enough

FRANKFURT - Bayer sought to dampen expectations that any proceeds from a separate listing of its plastics unit would be used for takeover deals to bolster its animal health activities.

30 Oct 2014

Bayer says animal health unit large enough

FRANKFURT, Oct 30 - Bayer sought to dampen expectations that any proceeds from a separate listing of its plastics unit would be used for takeover deals to bolster its animal health activities.

30 Oct 2014

Bayer says eyeing more deals after bulking up consumer care

FRANKFURT - Bayer is eyeing further takeover deals after wrapping up the acquisition of Merck & Co. Inc.'s consumer health business, the German drugmaker's chief executive said on Thursday.

30 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Sadif Analytics Prime
$10.00
Provider: ValuEngine, Inc.
$25.00
Provider: Finlabo SIM Spa
$10.00
Provider: Reuters Investment Profile
$20.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks